Table 1 Characteristics of HSCT patients
Total cases | AutoSCT | AlloSCT | |
|---|---|---|---|
Age (in years) | |||
Mean | 8.2 | 7.6 | 9.1 |
Median | 6.5 | 6 | 8.3 |
Standard deviation | 5.2 | 5.1 | 5.2 |
Minimum | 0.9 | 1 | 0.9 |
Maximum | 25 | 25 | 19.3 |
Sex | |||
Female | 190 | 114 | 76 |
Male | 335 | 197 | 138 |
Initial diagnosis | No (%) | No (%) | No (%) |
Neuroblastoma (NB) | 210 (40%) | 208 (66.9%) | 2 (0.9%) |
CR | 148 | 1 | |
Othersa | 60 | 1 | |
Non-Hodgkin lymphoma (NHL) | 21 (4%) | 11 (3.5%) | 10 (4.7%) |
1st CR | 2 | 1 | |
2nd CR | 9 | 9 | |
Acute myeloid leukemia (AML) | 76 (14.5%) | 2 (0.6%) | 74 (34.6%) |
1st CR | 1 | 43 | |
2nd CR | 1 | 31 | |
Acute lymphoblastic leukemia (ALL) | 44 (8.2%) | 1 (0.32%) | 43 (20.1%) |
1st CR | 0 | 26 | |
2nd CR | 1 | 17 | |
Myelodysplastic/myeloproliferative syndrome | 80 (15.2%) | 0 (0%) | 80 (37.3%) |
Hemophagocytic lymphohistocytosis (HLH) | 5 (1%) | 0 (0%) | 5 (2.3%) |
Hodgkin lymphoma (HL) | 77 (14.7%) | 77 (24.8%) | 0 (0%) |
Refractory | 63 | ||
Relapsing | 14 | ||
Relapsing Wilms’s | 2 (0.4%) | 2 (0.6%) | 0 (0%) |
Extraocular retinoblastoma (RB) | 10 (1.9%) | 10 (3.2%) | 0 (0%) |
Total | 525 (100%) | 311 (100%) | 214 (100%) |